“EVALUATING HEMATOLOGICAL AND INFLAMMATORY BIOMARKERS IN TUBERCULOSIS MANAGEMENT”, rjnmsr, vol. 4, no. 5, pp. 249–258, May 2026, doi: 10.63075/vk86y572.